Disc Medicine (IRON) Competitors $62.55 +3.00 (+5.04%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends IRON vs. ARDX, LSEA, QSI, PBYI, DBTX, LEGN, ELAN, BPMC, NUVL, and CYTKShould you be buying Disc Medicine stock or one of its competitors? The main competitors of Disc Medicine include Ardelyx (ARDX), Landsea Homes (LSEA), Quantum-Si (QSI), Puma Biotechnology (PBYI), Decibel Therapeutics (DBTX), Legend Biotech (LEGN), Elanco Animal Health (ELAN), Blueprint Medicines (BPMC), Nuvalent (NUVL), and Cytokinetics (CYTK). Disc Medicine vs. Ardelyx Landsea Homes Quantum-Si Puma Biotechnology Decibel Therapeutics Legend Biotech Elanco Animal Health Blueprint Medicines Nuvalent Cytokinetics Disc Medicine (NASDAQ:IRON) and Ardelyx (NASDAQ:ARDX) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, dividends, analyst recommendations, valuation, community ranking, institutional ownership, earnings, profitability and risk. Does the media prefer IRON or ARDX? In the previous week, Disc Medicine had 25 more articles in the media than Ardelyx. MarketBeat recorded 35 mentions for Disc Medicine and 10 mentions for Ardelyx. Disc Medicine's average media sentiment score of 0.66 beat Ardelyx's score of 0.20 indicating that Disc Medicine is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Disc Medicine 9 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Ardelyx 4 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Does the MarketBeat Community believe in IRON or ARDX? Ardelyx received 484 more outperform votes than Disc Medicine when rated by MarketBeat users. However, 83.64% of users gave Disc Medicine an outperform vote while only 67.52% of users gave Ardelyx an outperform vote. CompanyUnderperformOutperformDisc MedicineOutperform Votes4683.64% Underperform Votes916.36%ArdelyxOutperform Votes53067.52% Underperform Votes25532.48% Is IRON or ARDX more profitable? Disc Medicine has a net margin of 0.00% compared to Ardelyx's net margin of -28.82%. Disc Medicine's return on equity of -25.24% beat Ardelyx's return on equity.Company Net Margins Return on Equity Return on Assets Disc MedicineN/A -25.24% -23.96% Ardelyx -28.82%-46.60%-21.49% Do institutionals & insiders believe in IRON or ARDX? 83.7% of Disc Medicine shares are held by institutional investors. Comparatively, 58.9% of Ardelyx shares are held by institutional investors. 4.2% of Disc Medicine shares are held by insiders. Comparatively, 5.9% of Ardelyx shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Which has preferable earnings and valuation, IRON or ARDX? Ardelyx has higher revenue and earnings than Disc Medicine. Ardelyx is trading at a lower price-to-earnings ratio than Disc Medicine, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDisc MedicineN/AN/A-$76.43M-$3.98-15.72Ardelyx$124.46M9.36-$66.07M-$0.30-16.40 Which has more volatility and risk, IRON or ARDX? Disc Medicine has a beta of 0.6, meaning that its share price is 40% less volatile than the S&P 500. Comparatively, Ardelyx has a beta of 0.92, meaning that its share price is 8% less volatile than the S&P 500. Do analysts prefer IRON or ARDX? Disc Medicine presently has a consensus price target of $85.80, indicating a potential upside of 37.17%. Ardelyx has a consensus price target of $10.42, indicating a potential upside of 111.72%. Given Ardelyx's higher probable upside, analysts clearly believe Ardelyx is more favorable than Disc Medicine.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Disc Medicine 0 Sell rating(s) 0 Hold rating(s) 9 Buy rating(s) 1 Strong Buy rating(s) 3.10Ardelyx 0 Sell rating(s) 2 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 2.88 SummaryDisc Medicine beats Ardelyx on 9 of the 17 factors compared between the two stocks. Ad Angel PublishingTesla Execs are Freaking OutIt’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands on it. And Elon Musk has completely restructured Tesla to chase this opportunity. This is a once-in-a-lifetime opportunity that you don’t want to miss.Click here to get the details. Get Disc Medicine News Delivered to You Automatically Sign up to receive the latest news and ratings for IRON and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IRON vs. The Competition Export to ExcelMetricDisc MedicinePharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.77B$6.48B$5.05B$8.87BDividend YieldN/A8.12%4.97%4.06%P/E Ratio-15.725.5697.3414.18Price / SalesN/A348.141,218.4289.42Price / CashN/A22.1533.5132.79Price / Book3.977.885.805.12Net Income-$76.43M$153.61M$119.07M$225.99M7 Day Performance3.10%-2.00%-1.83%-1.32%1 Month Performance23.20%-7.47%-3.64%0.60%1 Year Performance20.87%31.80%31.62%26.23% Disc Medicine Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IRONDisc Medicine3.1622 of 5 stars$62.55+5.0%$85.80+37.2%+22.4%$1.77BN/A-15.7278Insider TradeAnalyst RevisionARDXArdelyx4.0014 of 5 stars$4.92+2.7%$10.42+111.7%+12.3%$1.17B$124.46M-16.40267Short Interest ↑LSEALandsea Homes4.1885 of 5 stars$10.55-1.9%$15.50+46.9%+7.5%$390.04M$1.21B14.65380QSIQuantum-Si2.5603 of 5 stars$1.39+120.6%$2.50+79.9%-12.0%$197.88M$2.27M-2.17150Options VolumeAnalyst RevisionGap UpHigh Trading VolumePBYIPuma Biotechnology4.4141 of 5 stars$2.84+3.6%$7.00+146.5%-27.0%$134.50M$235.60M5.92185Analyst ForecastPositive NewsDBTXDecibel TherapeuticsN/A$4.91-0.8%N/A+0.0%$123.39MN/A-1.9468High Trading VolumeLEGNLegend Biotech1.7588 of 5 stars$40.14+4.5%$81.46+102.9%-33.7%$7.00B$285.14M0.001,800Analyst RevisionELANElanco Animal Health4.1102 of 5 stars$13.44+1.0%$17.14+27.6%+13.1%$6.58B$4.42B33.609,300BPMCBlueprint Medicines2.713 of 5 stars$94.81+0.2%$122.11+28.8%+43.9%$6.02B$249.38M-44.93640Analyst ForecastNUVLNuvalent2.1677 of 5 stars$91.17+0.1%$112.60+23.5%+51.1%$5.90BN/A0.0040CYTKCytokinetics3.8052 of 5 stars$49.86-2.4%$83.67+67.8%+54.3%$5.88B$3.22M-9.27250Analyst ForecastInsider TradeOptions VolumeNews Coverage Related Companies and Tools Related Companies Ardelyx Alternatives Landsea Homes Alternatives Quantum-Si Alternatives Puma Biotechnology Alternatives Decibel Therapeutics Alternatives Legend Biotech Alternatives Elanco Animal Health Alternatives Blueprint Medicines Alternatives Nuvalent Alternatives Cytokinetics Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:IRON) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Disc Medicine, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Disc Medicine With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
